Janfada, M., Vahdat, S., & Kaviani, S. (2025). PI3K Signaling Pathway Inhibitor Affects Myeloma Cells in a Culture-Dependent Manner. Advanced Pharmaceutical Bulletin, 15(2), 440. https://doi.org/10.34172/apb.025.42774
Chicago Style (17th ed.) CitationJanfada, Mehrnaz, Sadaf Vahdat, and Saeid Kaviani. "PI3K Signaling Pathway Inhibitor Affects Myeloma Cells in a Culture-Dependent Manner." Advanced Pharmaceutical Bulletin 15, no. 2 (2025): 440. https://doi.org/10.34172/apb.025.42774.
MLA (9th ed.) CitationJanfada, Mehrnaz, et al. "PI3K Signaling Pathway Inhibitor Affects Myeloma Cells in a Culture-Dependent Manner." Advanced Pharmaceutical Bulletin, vol. 15, no. 2, 2025, p. 440, https://doi.org/10.34172/apb.025.42774.
Warning: These citations may not always be 100% accurate.